KOL Identification

Whether it’s a champion or a critic, insights from the right person will make all the difference. We can identify and connect you to the top, most influential minds in your space.

Our Experts

Pranay Madan

Katie Maloney

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

Research Tools

Sequencing Technology Go-to-Market Strategy

A research tools start-up enlisted DeciBio to support their go-to-market strategy and activities for their novel sequencing technology by conducting pricing voice-of-customer research and evaluating potential pricing strategies

View

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

Pharma & Biotech

Internal Lab Buildout Strategy

A large pharmaceutical company engaged DeciBio to evaluate strategies for an internal build of a lab to support clinical and commercial opportunities in oncology

View

Voice-of-Customer Research

Due Diligence

Clinical Diagnostics

Diagnostic Advisory Board

A diagnostics company requested DeciBio to help an advisory board (ad board) to understand how to position its relatively new somatic oncology genomics profiling product in an already competitive market

View

Voice-of-Customer Research

KOL Identification

Clinical Diagnostics

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

View

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Clinical Diagnostics

NIPT Market Landscape and Strategy

A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.

View

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Go-to-Market Strategy

Clinical Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

View

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch